Document is current
Any future updates will be listed below
-
Authors
Daly, Aideen B.
Boughton, Charlotte K. https://orcid.org/0000-0003-3272-9544
Nwokolo, Munachiso
Hartnell, Sara
Wilinska, Malgorzata E.
Cezar, Alina
Evans, Mark L. https://orcid.org/0000-0001-8122-8987
Hovorka, Roman https://orcid.org/0000-0003-2901-461X
- License Information
-
More Information
Article History
Received: 15 July 2022
Accepted: 23 November 2022
First Online: 11 January 2023
Competing interests
: C.K.B. has received consultancy fees from CamDiab and speaker honoraria from Ypsomed. M.N. has received travel grant support from Sanofi, Janssen and Eli Lilly and was previously chair of the Young Diabetologists’ and Endocrinologists’ Forum in the UK, which uses unrestricted sponsorship from industry partners to deliver educational programs for health care professionals. S.H. serves as a member of Sigma (Dexcom) and Medtronic advisory boards, as a director of Ask Diabetes (providing training and research support in health care settings) and as a consultant at CamDiab, and has received training honoraria from Medtronic and Sanofi. M.E.W. has received license fees from B. Braun and patents related to closed-loop insulin delivery, and reports being a consultant at CamDiab. M.L.E. has been a member of advisory panels and/or has received speaker fees from NovoNordisk, Eli Lilly, Abbott Diabetes Care, Medtronic, Ypsomed, Pila Pharma and Zucara. R.H. has received speaker honoraria from Eli Lilly, Dexcom and Novo Nordisk, license fees from B. Braun, and patents related to closed-loop insulin delivery, and is a director at CamDiab. A.D. and A.C. declare no competing interests.
